Advertisement

AIDS Team Publishes Article Despite Lawsuit

Upon presentation of their paper describing Remune's ineffectiveness, Kahn says it was clear they "did not present an analysis that the sponsor wanted."

"They wanted the right to review all manuscripts," Kahn said of Immune Response, which the researchers refused because it was "clear it was a way to delay publication."

Advertisement

Dr. Ronald B. Moss, vice president of medical and scientific affairs for Immune Response, refused to comment. Calls to the public relations office were not returned.

Both Kahn and Cheng stressed their duty to the patients who participated in the Remune study in publishing their negative data.

"Patients involved in research treatment should be involved with the outcome," Cheng said.

For the researchers, the Immune Response lawsuit endangers the larger issue of scientific freedom and places a conditional value on scientific research.

"They're sort of like bullies in a sandbox--they take their toys and escape," Kahn said of Immune Response.

Recommended Articles

Advertisement